S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The 3-Stock Retirement Blueprint (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The 3-Stock Retirement Blueprint (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The 3-Stock Retirement Blueprint (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The 3-Stock Retirement Blueprint (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
NYSE:SNN

Smith & Nephew - SNN Stock Forecast, Price & News

$23.22
+0.37 (+1.62%)
(As of 09/30/2022 09:02 PM ET)
Add
Compare
Today's Range
$23.15
$23.86
50-Day Range
$21.95
$29.35
52-Week Range
$21.77
$37.28
Volume
2.50 million shs
Average Volume
955,554 shs
Market Capitalization
$10.11 billion
P/E Ratio
N/A
Dividend Yield
2.41%
Price Target
N/A

Smith & Nephew MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.87% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.08mentions of Smith & Nephew in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.10%
From $1.57 to $1.76 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.37 out of 5 stars

Medical Sector

1055th out of 1,095 stocks

Surgical Appliances & Supplies Industry

24th out of 24 stocks

SNN stock logo

About Smith & Nephew (NYSE:SNN) Stock

Smith & Nephew PLC engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in Watford, the United Kingdom.

Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Stock News Headlines

Brokerages Set Smith & Nephew plc (NYSE:SNN) PT at $1,396.00
Smith & Nephew: Still A Buy Despite Short-Term Challenges
Smith & Nephew (NYSE:SNN) Reaches New 52-Week Low at $23.47
Smith & Nephew reports Q1 results
Top investment tips for a stocks and shares ISA
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Company Calendar

Last Earnings
11/17/2014
Ex-Dividend for 10/26 Dividend
9/29/2022
Today
10/02/2022
Dividend Payable
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Employees
18,000
Year Founded
1856

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$2.95 per share
Book Value
$12.66 per share

Miscellaneous

Free Float
430,951,000
Market Cap
$10.11 billion
Optionable
Optionable
Beta
0.62

Social Links


Key Executives

  • Deepak S Nath
    Chief Executive Officer & Director
  • Paul Connolly
    President-Global Operations
  • Anne-Francoise Nesmes
    Chief Financial Officer & Executive Director
  • Ian Melling
    Senior Vice President-Corporate Finance
  • Alison Parkes
    Chief Compliance Officer













SNN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.
View SNN analyst ratings
or view top-rated stocks.

How have SNN shares performed in 2022?

Smith & Nephew's stock was trading at $34.62 at the beginning of 2022. Since then, SNN shares have decreased by 32.9% and is now trading at $23.22.
View the best growth stocks for 2022 here
.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest in September. As of September 15th, there was short interest totaling 3,770,000 shares, an increase of 62.5% from the August 31st total of 2,320,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the days-to-cover ratio is presently 3.1 days. Approximately 0.9% of the shares of the company are sold short.
View Smith & Nephew's Short Interest
.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) released its quarterly earnings data on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.59.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Monday, August 1st. Stockholders of record on Friday, September 30th will be given a dividend of $0.288 per share on Wednesday, October 26th. This represents a dividend yield of 2.8%. The ex-dividend date is Thursday, September 29th.
Read our dividend analysis for SNN
.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.56 per share and currently has a dividend yield of 2.41%.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $23.22.

How much money does Smith & Nephew make?

Smith & Nephew (NYSE:SNN) has a market capitalization of $10.11 billion and generates $5.21 billion in revenue each year.

How many employees does Smith & Nephew have?

The company employs 18,000 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353.

This page (NYSE:SNN) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.